Europe
BBC Business

Why has Texas set its sights on London?

In the dimly lit cellars of London's oldest wine merchant, Texas is not the first thing that springs to mind. But nearly 200 years ago, Berry Bros & Rudd was home to the Embassy of the Republic of Texas. If you look closely, you can see a remaining "Texan Legation" plaque on the wall outside the St James's Street store. After Texas joined the US in 1845, the embassy closed - and the Texan diplomats headed home, apparently leaving behind an unpaid rent bill. Now, two centuries later, the State of Texas has opened a dedicated new office just up the road to "grow international trade and tourism and support activities that are key to the economy". Trade between Texas and the UK is already worth about $17bn a year, and the state wants even closer business ties. "One of the things that was very compelling to me is the opportunity to look at dual listings between the London Stock Exchange and the Texas Stock Exchange," says Senator Tan Parker of Texas North and Republican leader of the Texas State Senate. He adds he hopes it will create jobs and opportunities for small and large businesses - both in Texas aiming to enter the UK market, and British companies that want to enter the Texas market. It comes as the state's capital Austin raises the profile of its own stock exchange as a challenger to New York, known as "Y'all Street". "Austin 25 years ago was becoming a big international city and we are doing a lot to mature our way into that international role," the city's mayor, Kirk Watson, tells BBC London. "I also think places like London get something out of these relationships because we talk about things like Austin energy - our municipally-owned utility - renewables, and climate." He also stressed the importance of cities working together to address the growth of artificial intelligence and data centres, and how to implement them in dense urban settings.

Why has Texas set its sights on London?
North America
CNBC Finance

UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency

UniQure plans to seek FDA approval of its experimental gene therapy for Huntington's disease, the company said Wednesday, months after previous agency leaders criticized the evidence backing the application. UniQure said the FDA in a recent meeting communicated that a three-year analysis from a Phase 1/2 study would support an accelerated approval of UniQure's gene therapy for Huntington's, a rare hereditary disease that gradually destroys nerve cells in the brain. As a result of the meeting, UniQure plans to submit its application to the FDA in the third quarter of this year. An FDA official confirmed that the agency and the company have agreed on a path for submission for a marketing application and accelerated approval of the therapy based on the existing clinical data. The FDA "remains committed to working with UniQure to identify a regulatory pathway that serves patients with Huntington's disease and their families, while upholding the agency's commitment to gold-standard science," the official said in a statement. The new FDA guidance represents a stunning reversal from March, when the regulator told Uniqure that its clinical trial data wouldn't support an application and publicly criticized the company. UniQure became a prime example in a series of reversals where companies said the FDA had changed its previous guidance, hitting rare disease drugmakers especially hard. Many of those decisions happened under former FDA Commissioner Marty Makary, who left the agency in May. In a February interview with CNBC's Becky Quick, then-Commissioner Makary described UniQure's treatment without naming it, saying the agency was pressured to approve it even though it showed "no benefit." Then UniQure said the FDA couldn't agree that data from a clinical trial comparing UniQure's gene therapy to an external control are sufficient to support an application. A senior FDA official at the time confirmed to reporters that the FDA wanted UniQure to run a placebo-controlled trial to prove its therapy "actually helps people." The gene therapy is administered directly into the brain through an hours-long surgery, and UniQure has said it would be unethical to make people undergo a sham procedure. Instead, the company compared the progression of people who received the treatment to the typical progression of Huntington's disease using an outside database. Using that approach, UniQure's gene therapy slowed disease progression by 75% in a Phase 1/2 trial. With the FDA's blessing, UniQure now plans to use the same data that came under scrutiny to support its application. An accelerated approval would allow UniQure's treatment to come to market on the condition that the company prove the benefit in another study. UniQure on Wednesday said the FDA wants to align on that study's design, including comparing the treatment to the current standard of care rather than a sham procedure. UniQure said it's committed to conducting that study and expects to finalize those plans before submitting its application. UniQure isn't the only company to see its fortunes reverse following the departure of Makary and other senior leaders, including former Center for Biologics Evaluation and Research director Vinay Prasad and former Center for Drug Evaluation and Research director Tracy Beth Høeg. Replimune recently announced it would seek approval of its experimental melanoma drug for a third time. Get this delivered to your inbox, and more info about our products and services. Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

UniQure to seek FDA approval for Huntington's disease gene therapy after previous clash with agency
North America
CNBC Finance

Target, Walmart and Amazon among brands losing LGBTQ+ consumer spending, new survey says

LGBTQ+ consumers are shifting their brand loyalties based on companies' diversity, equity and inclusion policies, according to new research from the Human Rights Campaign Foundation. The findings released Wednesday found that nearly 72% of LGBTQ+ consumers say they buy fewer products from companies they perceive as "reducing diversity and inclusion commitments." Nearly 70% also said they have refused purchases from those businesses at least some of the time. The five companies those respondents most frequently linked to reduced spending were Target, Walmart, Amazon, Chick-Fil-A and Home Depot. On the other hand, HRC's survey found nearly 70% of LGBTQ+ consumers are also rewarding companies they view as supportive of diversity and inclusion. Costco, Apple, Ben & Jerry's, Delta Air Lines and Kroger were the five companies most frequently cited as recipients of higher spending. "Consumers aren't asking the brand to be perfect they're asking them to be transparent and clear on where they stand," said Human Rights Campaign spokesman Jonathan Lovitz. "There is a gap to close between perception and what you're doing inside," he said. HRC's survey was conducted online from Sept. 29 through Oct. 27, among roughly 15,000 U.S. adults, including about 10,000 LGBTQ+ respondents and 5,000 non-LGBTQ+ respondents. The survey comes as a growing number of companies have scaled back diversity initiatives, modified public-facing DEI programs or ended participation in the organization's annual Corporate Equality Index. Earlier this year, HRC reported a sharp decline in participation in the index, a benchmark that has long measured workplace policies and benefits for LGBTQ+ employees. Participation among Fortune 500 companies fell 65% from 377 companies in 2025 to 131 in 2026. In response to the survey, Amazon told CNBC it is fostering opportunities for employees and serving a diverse customer base. "We've continued to support our employees with opportunities that allow them to grow, thrive and connect internally and in their communities," said a company spokesperson. U.S. shoppers have increasingly mobilized for or against companies based on their DEI policies. Target, for instance, has faced consumer backlash from both sides of the political spectrum over its approach and was the most cited company among survey respondents who said they reduced their spending. Self-identified Republicans reduced spending at Target during the summer of 2023 following controversy surrounding the retailer's Pride Month merchandise display, according to spending data from Consumer Edge. In early 2025, spending among self-identified Democrats also declined after the company rolled back several DEI initiatives.

Target, Walmart and Amazon among brands losing LGBTQ+ consumer spending, new survey says
Europe
BBC Business

Oil prices slide after Pakistan announces deal between US and Iran

Oil prices fell in Asia on Monday after Pakistan, which has been mediating an end to the US-Iran war, announced a deal that President Donald Trump said would see the reopening of the key Strait of Hormuz shipping route. Brent crude, the global oil benchmark, was 4.8% lower at $83.18 (£61.89) a barrel, while US-traded oil was down 5.6% at $80.13. Pakistan's prime minister Shehbaz Sharif said an official signing ceremony would be held on Friday, 19 June in Switzerland. Iran's Deputy Foreign Minister Kazem Gharibabadi confirmed in a phone call on state TV that a deal with the US had been finalised, while Trump posted on social media "let the oil flow!". But Vandana Hari from energy markets analysis firm Vanda Insights said a lack of detail on what has been agreed "is likely to inject unease and uncertainty into the market." This could mean a week of uncertainty and volatility for the oil market, she added. The Strait of Hormuz had been effectively closed since shortly after the US and Israel launched airstrikes on Iran on 28 February. Tehran had threatened to attack vessels using the crucial waterway, through which around 20% of the world's oil and liquefied natural gas (LNG) normally passes. Global energy markets have been on a wild ride in recent months, with prices often rising or falling sharply in response to developments in the US-Israel war with Iran. Brent crude, which was trading at around $70 a barrel before the conflict started, peaked at about $120 during the war. Energy market experts have also warned that the movement of oil through the strait is unlikely to immediately return to pre-war levels. Andrew Lipow from consulting company Lipow Oil Associates said mines would first need to cleared from the waterway, which could take from a few weeks to up to six months.

Oil prices slide after Pakistan announces deal between US and Iran
Europe
BBC Business

'We had to get out of the way': The backlash over delivery robots

The first time Chicago resident John Roberts saw a delivery robot trundling down the sidewalk on his street he was impressed. But his attitude started to change when, soon after, he was out for a walk with his family. As another robot approached, they found themselves having to dodge it. "To us it felt a little off - the fact that we were on the one strip reserved for walking, and we were having to get out of the way," says Roberts. "I started thinking about what it would be like for us to go for a walk as a family if there were dozens of robots with lights and cameras zipping around." The robots, more formally known as autonomous urban delivery vehicles, have started to appear on pavements in a number of cities across the US, plus in the UK, Japan, South Korea and Germany, transporting groceries and fast food, using cameras, sensors and GPS to navigate. According to the companies operating them, they can reliably identify and avoid objects in the path, cross streets safely and react to their environment. The robots provide a useful service and help cut down on traffic and emissions, they claim. However, some local authorities in the US and Canada, and members of the public, are less than enthusiastic. Bans have been put in place, and protests have been launched. San Francisco has limited the access of the vehicles to less busy parts of the city, and Toronto has since 2021 prohibited the robots from using sidewalks. Meanwhile, in Chicago the machines have now been banned from two small areas of the city. Roberts wants the robots to be suspended across all of Chicago until safety tests are carried out, and clear rules are set on their usage. He has launched a petition calling for this, and so far, it has around 4,400 signatures. People frequently find themselves having to step into the street in order to get out of the machines' way, says Roberts. "There have been reports of collisions and injuries. I saw one a few days ago where somebody had been struck by one of the robots' safety flags, which is a little ironic," he says. "We've got reports of robots causing issues with traffic, blocking emergency vehicles because they're acting erratically at crosswalks." Similar concerns have emerged in Glendale, California, where the local council is considering a temporary ban on the use of the vehicles. Councillors say the robots appeared without warning, and at first they didn't even know which company was supplying them.

'We had to get out of the way': The backlash over delivery robots
North America
CNBC Finance

CNBC to wade further into live sports with 11 simulcast WNBA games

CNBC parent Versant announced Wednesday that the business news network will simulcast 11 WNBA games this season. The matchups will also air on Versant's USA Network. Last September, Versant and the WNBA announced an 11-year media rights agreement that includes both regular-season and postseason games. As part of that deal, USA Network will air at least 50 games annually. Coverage on CNBC begins Wednesday night with the defending champion Las Vegas Aces taking on the Phoenix Mercury at 10 p.m. ET. That game is the second of a doubleheader that kicks off with the New York Liberty and Chicago Sky at 8 p.m. ET on USA Network. The goal of the simulcasts is to ensure that fans don't miss any of the action, according to USA Sports President Matt Hong. As doubleheaders can occasionally run long, the simulcast will allow viewers to choose which game to tune into if they overlap. The simulcast will also expose the WNBA to an affluent audience on CNBC as the league seeks to capitalize on booming popularity. "It's really a promise that we make to not only the WNBA, but all our league partners that we'll look for new audiences for them," Hong said Wednesday on CNBC's "Squawk Box." Wednesday also marks the debut of Indiana Fever guard Sophie Cunningham as an athlete contributor for Versant. She will be involved in studio coverage for both games of the doubleheader on both networks. The simulcast agreement marks a fresh chapter for CNBC as it explores new revenue streams and navigates a corporate spinout from its former parent, Comcast. While CNBC has previously carried Olympic events and occasional golf events, the WNBA simulcast represents a further push into live sports for the cable channel. "Sports is obviously must-see television. I'd put live news and live financial news in that category as well," said Hong. That could help Versant in future distribution deals with pay TV providers. Versant is now negotiating these carriage deals on its own after previously tying its programming to NBCUniversal when it was part of Comcast. Since news of Versant's spin-off, Hong has signed five new, expanded or extended rights deals.

CNBC to wade further into live sports with 11 simulcast WNBA games
North America
Yahoo Finance

Nasdaq, S&P 500, Dow Futures Climb While Oil Slides As US-Iran Deal Signals End To Hormuz Disruption: DJT, NFLX, GLXY, SPCX In Focus

U.S. stock futures climbed in the overnight session heading into Monday and oil prices fell lower after the U.S. and Iran reached a deal to reopen the Strait of Hormuz after months of conflict. Dow futures were trading up by 0.73%, S&P 500 futures climbed nearly 1%, while Nasdaq 100 futures traded 1.60% higher as of 8.46 p.m ET. The iShares 20+ Year Treasury Bond ETF (TLT) was also trading 0.59% higher amid ‘neutral’ sentiment at the time of writing. On Friday, all three benchmark indexes closed higher following a blockbuster debut of Elon Musk’s SpaceX. The Dow led the uptick, closing 0.70% higher after adding more than 350 points. The S&P 500 ended the session 0.50% higher and the Nasdaq was up 0.31% at close. The U.S. and Iran have confirmed that a peace framework to end the war has been reached, which will result in the reopening of the Strait of Hormuz after more than 16 weeks of being shut. “The Deal with the Islamic Republic of Iran is now complete. Congratulations to all!” said U.S. President Donald Trump on Sunday in a post on Truth Social. The president added that the Strait of Hormuz would be open and that “the immediate removal of the United States Naval blockade” would allow ships to pass through the critical waterways. “Ships of the World, start your engines. Let the oil flow!” he said. In a separate post, Trump said that the Strait would open on Friday following a signing of the deal. “This Great Deal will bring Peace and Security to the whole Region. Many presidents have tried to make Peace with Iran, and all have failed before me. The Leaders of the Region have, for the first time, found a President who can help them achieve real Peace. With the opening of the Strait upon the signing of the Deal on Friday, for purposes of mine removal, oil will flow on both ends again for the Region, and the World!” he said. Earlier in the day, Pakistani Prime Minister Shehbaz Sharif confirmed the deal in a post on X, saying, “Following intensive talks, we are pleased to announce that the Peace Deal between the United States of America and Islamic Republic of Iran has been REACHED. Both sides have declared the immediate and permanent termination of military operations on all fronts, including in Lebanon.” Sharif added that the official signing ceremony will be completed in Switzerland on June 19. “Markets have been waiting for this news for months, and the relief is already showing, with oil sliding and risk assets catching a bid,” Josh Gilbert, lead analyst for Asia Pacific and the Middle East at eToro Ltd, said to Bloomberg.

Nasdaq, S&P 500, Dow Futures Climb While Oil Slides As US-Iran Deal Signals End To Hormuz Disruption: DJT, NFLX, GLXY, SPCX In Focus
Europe
The Guardian

Paramount rejected ad criticizing its owners and Warner Bros acquisition

David Ellison, CEO of Paramount Skydance. Photograph: Brendan McDermid/ReutersView image in fullscreenDavid Ellison, CEO of Paramount Skydance. Photograph: Brendan McDermid/ReutersUS newsParamount rejected ad criticizing its owners and Warner Bros acquisitionRejected citing ‘conflict of interest’, the ad took aim at Trump allies David Ellison, Paramount Skydance chief, and his billionaire father, Larry Ellison Paramount Skydance refused to air an ad submitted by a press freedom group that heavily criticized the network’s leadership and merger with Warner Bros Discovery, with an advertising associate deeming it a “conflict of interest”. The Freedom of the Press Foundation had hoped to air the 30-second ad during Sunday’s Ultimate Fighting Championship broadcast at the White House, which aired on the streaming service Paramount+ – though a client partner for Paramount+ told the organization’s ad-buyer that such placement was not guaranteed. “Instead of defending press freedom, CBS’ billionaire owners cut deals and caved to Trump,” the unaired ad states, before touching on the recent uproar at the Sunday show 60 Minutes. “One fired reporter said, ‘CBS demanded falsehoods and bias to appease Trump.’ Now Trump wants the Ellisons to buy CNN, too … Let’s stop Trump’s censorship and block this merger.” According to an email exchange between Paramount’s ad salesperson and the Freedom of the Press Foundation’s ad buyer, viewed by the Guardian, the discussion about running an ad was going smoothly until the ad was actually submitted. (The organization was told that ads running during the UFC broadcast would cost approximately $300,000.) Then, on Friday afternoon, two days before the fight, the Paramount salesman sent word that the ad could not run. “Unfortunately, the creative you submitted was a conflict of interest so it was not approved,” the sales representative said. “But we can help you check any other creatives you want to try. Always happy to hop on a call to discuss more.” Seth Stern, chief of advocacy for Freedom of the Press Foundation, criticized Paramount for refusing to air the ad – although television networks regularly reject advocacy messages for a variety of reasons. “Ellison has already shown his cards on editorial independence, but, in case there was any doubt, his company has now declined to air a straightforward message about what his proposed takeover of CNN, HBO, and other outlets would mean for press freedom. Instead, it censored it,” Stern said in a statement. “Ellison won’t air criticism of himself, his company, or his buddy Trump. These antics are bad for press freedom, bad for the public, and bad for Paramount – just look at CBS’ recent struggles under Ellison’s watch.” Stern’s organization instead plans to air the ad on its website dedicated to opposing the merger, which received approval from Donald Trump’s Department of Justice on Friday but still faces regulatory hurdles outside the United States.

Paramount rejected ad criticizing its owners and Warner Bros acquisition
Asia
The Economic Times

IFCI, HFCL among 14 stocks that rallied up to 50% in just one month - Do you own any?

While the headline indices moved at a calm pace, the real action was happening beneath the surface. Over the past month, the benchmark BSE Sensex climbed around 2.5%, and the BSE 500 mirrored the same gain. However, hidden inside the BSE 500 was a burst of momentum, as nearly 92 stocks delivered double-digit returns. Even more striking, 14 of them turned into market sprinters, rallying between 25% and 50% in just a single month. It was a reminder that while the index walked steadily, several individual stocks were already running a marathon at sprint speed. (Data Source: ACE Equity) In the past one month, the stock surged 49% from Rs 675 to Rs 1,007 and is currently close to its 52-week high of Rs 1,017. In the past one month, the stock jumped 42% from Rs 63 to Rs 90. Its 52-week high stands at Rs 96. In the past one month, the stock gained 35% from Rs 445 to Rs 602. The stock’s 52-week high is Rs 732. In the past one month, the stock rallied 32% from Rs 899 to Rs 1,184. Its 52-week high stands at Rs 1,257. In the past one month, the stock advanced 31% from Rs 1,546 to Rs 2,023. The stock touched a 52-week high of Rs 2,420. In the past one month, the stock climbed 29% from Rs 70 to Rs 90. Its 52-week high stands at Rs 118. In the past one month, the stock rose 28% from Rs 148 to Rs 190. The stock’s 52-week high is Rs 209. In the past one month, the stock gained 28% from Rs 1,013 to Rs 1,298. Its 52-week high stands at Rs 1,333. In the past one month, the stock rallied 28% from Rs 3,841 to Rs 4,914. The stock’s 52-week high is Rs 5,042. .In the past one month, the stock surged 27% from Rs 12,645 to Rs 16,080. Its 52-week high stands at Rs 16,475. In the past one month, the stock moved up 27% from Rs 289 to Rs 366. The stock’s 52-week high is Rs 531.

IFCI, HFCL among 14 stocks that rallied up to 50% in just one month - Do you own any?